AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| ASF | Ann: ASF NTA 23-04-2018 $7.25388 | 24/04/18 | 0 | 6 | |||
|
|||||||
| ASF | Ann: ASF NTA 20-04-2018 $7.22034 | 23/04/18 | 0 | 13 | |||
|
|||||||
| ASF | Ann: ASF NTA 19-04-2018 $7.20596 | 20/04/18 | 0 | 17 | |||
|
|||||||
| ASF | Ann: ASF NTA 18-04-2018 $7.20821 | 19/04/18 | 0 | 17 | |||
|
|||||||
| ASF | Ann: ASF NTA 17-04-2018 $7.19802 | 18/04/18 | 0 | 21 | |||
|
|||||||
| ASF | Ann: ASF NTA 16-04-2018 $7.22071 | 17/04/18 | 0 | 23 | |||
|
|||||||
| ASF | Ann: ASF NTA 13-04-2018 $7.20309 | 16/04/18 | 0 | 15 | |||
|
|||||||
| ASF | Ann: ASF NTA 12-04-2018 $7.21827 | 13/04/18 | 0 | 22 | |||
|
|||||||
See All Discussions
NZX News